Big Move For Trillium Therapeutics Inc.

Fri 28 Feb 20 at 05:30 PM
Big Move For Trillium Therapeutics Inc.

Trillium Therapeutics Inc. (TRIL:NASDAQ) shot up at $5.05, a gain of 62.9%. On Thu 27 Feb 20, TRIL:NASDAQ hit a New 2-Week Low of $3.1. The stock appeared on our News Catalysts scanner on Mon 10 Feb 20 at 07:01 AM in the 'BIOTECH' category. From Thu 06 Feb 20, the stock recorded 50.00% Up Days and 26.67% Green Days

The stock spiked on Fri 24 Jan 20 at $4.86 with a volume of 11M+.

About Trillium Therapeutics Inc. (TRIL:NASDAQ)

Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.

Share